Sonim Technologies prices public offering of 7.4M shares at $0.75, raising ~$4.9M net

DNA X, Inc.

Offering of 7,400,000 common shares at $0.75 per share closed July 2, 2025.
Net proceeds estimated at $4.9 million after placement agent fees and expenses.
Placement agent Roth Capital Partners receives 7% cash fee and warrants for 208,875 shares.
Proceeds to be used for working capital, general corporate purposes, and potential debt repayment.
Registration statement (S-1) was declared effective by SEC on June 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.